SCHEMBL6980253

SCHEMBL6980253

COc1ccc(Cl)c(Nc2ncnc3cc(O)cc(OCCCC4CCNC4)c23)c1

nearest known ligand 0.53

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
SRC P12931 17/20 0.53
KDR P35968 10/20 0.48
EGFR P00533 2/20 0.42
RET P07949 1/20 0.41
KIF5B P33176 1/20 0.41
FGFR1 P11362 1/20 0.39
FLT1 P17948 1/20 0.39
FLT4 P35916 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6968068 0.88 SRC (0.53) SRCKDREGFR
SCHEMBL3282453 0.79 SRC (0.73) SRCKDR
SCHEMBL3276140 0.77 SRC (0.86) SRCKDR
SCHEMBL3276553 0.77 SRC (0.69) SRCKDREGFR
SCHEMBL3279077 0.76 SRC (0.77) SRCKDREGFR
SCHEMBL3280052 0.76 SRC (0.67) SRCKDREGFRRETKIF5B
SCHEMBL3275923 0.74 SRC (0.70) SRCKDREGFR
SCHEMBL3282736 0.74 SRC (0.57) SRCKDREGFRRETKIF5B
SCHEMBL3282155 0.72 SRC (0.55) SRCKDREGFR
SCHEMBL3274759 0.72 SRC (0.77) SRCKDRRETKIF5B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2001094341-A9 QUINAZOLINE DERIVATIVES FOR THE TREATMENT OF TUMOURS ASTRAZENECA AB (SE) 2003-04-17 WO disclosed
EP-1292594-A1 QUINAZOLINE DERIVATIVES FOR THE TREATMENT OF TUMOURS AstraZeneca AB (SE) 2003-03-19 EP disclosed
WO-2001094341-A1 QUINAZOLINE DERIVATIVES FOR THE TREATMENT OF TUMOURS ASTRAZENECA AB (SE) 2001-12-13 WO disclosed